Red X iconGreen tick iconYellow tick icon

Contact Details

Phone
+64 27 435 9552
Email
rob.walker@otago.ac.nz
Position
Professor of Medicine, Consultant Nephrologist
Department
Department of Medicine (Dunedin)
Qualifications
MB ChB MD(Otago) FRACP FAHA FASN
Research summary
Translational and clinical kidney research
Teaching
Undergraduate and postgraduate teaching in Medicine
Memberships
  • Life membership Australian & New Zealand Society of Nephrology
  • Life membership Royal Australasian College of Physicians
  • Life membership Otago Medical Research Foundation
  • Co-Chair Research Advisory Committee ANZSN
  • Member Education and Training Committee ANZSN
  • Member RACP Advance Training Committee Nephrology
  • Member of Asia Pacific Society of Nephrology Executive Committee
  • Chair of the International Society of Nephrology Clinical Research Committee
  • Chair International Society of Nephrology Core Programme Committee
Clinical
Consultant Nephrologist for the Southern Region NZ

Research

At a clinical level my research programme is based around cardiovascular risk factors in CKD and drug handling in Chronic Kidney Disease. I am involved in numerous studies including as PI on an HRC funded study on dialysis outcomes in the elderly (10/354), co-investigator in the HRC funded programme grant (16/604) and current programme grant (24-690) under review– Dunedin Multidisciplinary Health and Development Study investigating predictors of longitudinal changes in kidney function, IMPEDE-PKD (23/093), Teach-PD (19/290), the Phosphate study (HRC 19/268), CKD-FIX (14/117), (on 4 NH&MRC; funded grants (SHARPER, CKD FIX, IMPROVE, INCH-HD) and I am a member of the International steering group for SHARP (lipid lowering in CKD coordinated via Oxford University). Also co-principal investigator on an earlier HRC funded Early ARF study. I am the NZ principal investigator for a number of Pharma sponsored Phase 3 clinical trials as well as my own investigator-initiated clinical studies including investigating the impact of renal denervation in ESKD patients on dialysis, measuring the changes in sympathetic nerve activity and impact on cardiac function; investigating drug handling in dialysis patients; mechanisms of cramp in CKD and dialysis patients; and drug pharmacokinetics in CKD patients.

Principal Investigator Biomedical Science - nephrology. My MD investigated the cellular mechanisms of cyclosporin nephrotoxicity. Since then the main focus of my biomedical research programme has been on mechanisms of renal cellular injury and renal fibrosis, in particular, mechanisms of lithium-induced chronic interstitial fibrosis. In addition current research is also focused on animal models of cardio-renal syndrome exploring the close links between hypertension, heart disease and chronic kidney disease. A key component of my research programme has been the integration of biomedical science into clinical applicability as evident with my acute kidney injury work, lithium-induced kidney injury and cardio-renal interactions. This work has been recognised with an HRC 2023 NZ-China Biomedical Research Alliance Fund award for ‘Elucidating pathways of kidney injury and repair – new therapeutic options?’

H-Index 51. Citations: over 12,000 to date. PBRF ‘A’ ranking.

Additional details

Director University of Otago Research Theme: The Kidney in Health and Disease.

Publications

Fordyce, A. M., Heenan-Vos, F., Putt, T. L., Donnellen, S., Schollum, J. B. W., & Walker, R. J. (2024). An unusual case of Herbaspirillum huttiense bacteraemia in a haemodialysis patient. Nephrology. Advance online publication. doi: 10.1111/nep.14385 Journal - Research Other

Walker, R. (2024, March). Chronic kidney disease and CVD risk. Verbal presentation at the Goodfellow Symposium: Skills for Next Monday, Auckland, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs

Florance, J. A., Schollum, J. B. W., Pomeranc, A., Endre, Z. H., & Walker, R. J. (2024). Autosomal dominant hypercalciuric hypocalcaemia: The calcium-sensing receptor in renal calcium homeostasis and the impact of renal transplantation. Internal Medicine Journal. Advance online publication. doi: 10.1111/imj.16403 Journal - Research Other

Cashmore, B., Tunnicliffe, D. J., Palmer, S., Blythen, L., Boag, J., Kostner, K., … Patu, M., … Walker, R., on behalf of the CARI Guidelines Steering Committee. (2024). Australian and New Zealand Living Guideline cholesterol-lowering therapy for people with chronic kidney disease (CARI Guidelines): Reducing the evidence-practice gap. Nephrology, 29(8), 495-509. doi: 10.1111/nep.14295 Journal - Research Article

Wilson, L. C., Ward, J., Wright, D. F. B., Green, S. C., Stocker, S. L., Putt, T. L., Schollum, J. B. W., & Walker, R. J. (2024). The impact of peritoneal dialysis on oxypurinol and urate elimination in people with gout. Nephrology, 29, 547-550. doi: 10.1111/nep.14306 Journal - Research Other

Back to top